274 related articles for article (PubMed ID: 11588110)
1. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.
Izzo AA; Fezza F; Capasso R; Bisogno T; Pinto L; Iuvone T; Esposito G; Mascolo N; Di Marzo V; Capasso F
Br J Pharmacol; 2001 Oct; 134(3):563-70. PubMed ID: 11588110
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.
Izzo AA; Pinto L; Borrelli F; Capasso R; Mascolo N; Capasso F
Br J Pharmacol; 2000 Apr; 129(8):1627-32. PubMed ID: 10780967
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids as physiological regulators of colonic propulsion in mice.
Pinto L; Izzo AA; Cascio MG; Bisogno T; Hospodar-Scott K; Brown DR; Mascolo N; Di Marzo V; Capasso F
Gastroenterology; 2002 Jul; 123(1):227-34. PubMed ID: 12105851
[TBL] [Abstract][Full Text] [Related]
4. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
[TBL] [Abstract][Full Text] [Related]
5. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.
Capasso R; Izzo AA; Fezza F; Pinto A; Capasso F; Mascolo N; Di Marzo V
Br J Pharmacol; 2001 Nov; 134(5):945-50. PubMed ID: 11682441
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
Capasso R; Borrelli F; Aviello G; Romano B; Scalisi C; Capasso F; Izzo AA
Br J Pharmacol; 2008 Jul; 154(5):1001-8. PubMed ID: 18469842
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
[TBL] [Abstract][Full Text] [Related]
9. Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
Izzo AA; Mascolo N; Borrelli F; Capasso F
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):65-70. PubMed ID: 9933153
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
11. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
13. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.
Pertwee RG; Fernando SR; Nash JE; Coutts AA
Br J Pharmacol; 1996 Aug; 118(8):2199-205. PubMed ID: 8864562
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
[TBL] [Abstract][Full Text] [Related]
17. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
Landi M; Croci T; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Manara L
Eur J Pharmacol; 2002 Aug; 450(1):77-83. PubMed ID: 12176112
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]